Homozygous Familial Hypercholesterolemia (HoFH) - Pipeline Review, H2 2016
"Homozygous Familial Hypercholesterolemia (HoFH) - Pipeline Review, H2 2016" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Homozygous Familial Hypercholesterolemia (HoFH) Pipeline Review, H2 2016, provides an overview of the Homozygous Familial Hypercholesterolemia (HoFH) (Metabolic Disorders) pipeline landscape. Get Sample Report With TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid=889507 Homozygous familial hypercholesterolemia is a genetic disorder which is caused due to mutation from both parents. HoFH causes LDL cholesterol level to be very high. Symptoms include xanthelasmas, chest pain and sores on the toes that do not heal. Treatment includes diet changes and statin drugs. Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline